The Cellarian Story
Cellarian was founded by Dr. Michael Sprintz, a triple board-certified physician and a nationally recognized subject matter expert on chronic pain and addiction with over twenty-three years in personal recovery from substance abuse. Dr. Sprintz also founded a comprehensive clinical practice in The Woodlands, Texas, focused on treating patients with chronic pain and/or substance use disorders. He is a certified Medical Review Officer and was a member of the American Society of Addiction Medicine’s (ASAM) Drug Testing Expert Panel, which in 2017, published the most thorough recommendations on appropriate clinical drug testing to date.
As a clinician expert in chronic pain and addiction, Dr. Sprintz understood the importance of drug testing as part of good patient care balanced with cost-effective appropriateness of testing. However, he became frustrated with egregious payment denial strategies of health insurance companies towards drug testing and decided to solve this ever-growing problem. He designed an algorithm to help providers and labs rapidly create the necessary documentation to support appropriate drug testing, while preventing unnecessary testing and overuse. Joining together with a seasoned team of experts, industry and health IT specialists, Cellarian was born.
Cellarian is a SaaS health IT company committed to developing automated solutions that empower labs, generate revenue, decrease risk, and improve patient outcomes.
EXECUTIVE TEAM
-
Michael Sprintz, DO, DFASAM, Founder/CEO
Dr. Sprintz is triple board-certified in Pain Medicine, Addiction Medicine, and Anesthesiology, and trained at Johns Hopkins (Anesthesiology) and MD Anderson Cancer Center (Pain Medicine). Importantly, Dr. Sprintz is personally in recovery from drug addiction for over 18 years and founded Sprintz Center for Pain & Recovery, an integrated outpatient private practice that specializes in the comprehensive management of chronic pain & substance use disorders. Dr. Sprintz serves as a member of the FDA’s Analgesic & Anesthetic Drug Products Advisory Committee & is a member of the Joint Commission Standards Review Panel for Pain Assessment & Management, as well as the Joint Commission's Technical Advisory Panel for Pain Assessment & Management in Behavioral Healthcare. Dr. Sprintz is the Past-President of the Texas Society of Addiction Medicine, & a member of the American Society of Addiction Medicine’s Drug Testing Expert Panel, Payer Relations Committee, & the Pain & Addiction Educational Program Planning Committee.
-
Michael C. Lu, MBA/HCM, ALM, President & COO
Mike Lu is the Chief Operating Officer for Cellarian Inc. Mr. Lu is a seasoned hospital and healthcare administrator, and his former company was one of the first clients for the CellarianRx product line. He knows firsthand the impact that Cellarian can make within the health marketplace. Mike is committed to the operational application of transformative medical innovation that addresses the challenges and unmet needs of society. He has deep operational experience from startups to Fortune 100. Mike has an MBA in Healthcare Management and a Masters in Strategic Management. A former healthcare & management consultant with McKinsey & Co, Mike is a Harvard-trained healthcare administrator with a commitment to the application of transformative medical innovation that addresses the challenges & unmet needs of society. A former officer in the Strategic Air & Materiel Commands for the US Air Force Reserves, Mike is a member of the AHA, AAHC and ACHE.
-
Ian Williamson, CTO
Ian Williamson is a full stack software developer with over 20 years of experience working with leading edge technologies for a wide variety of industries (TV, Film, Museum Interpretive Media, and Web Development). He brings a clear head to every project and crafts the best solutions to solve problems, even when they require a non-standard approach. As Cellarian Health CTO, Ian has designed and developed Vision from the ground. Ian is passionate about creating software to help solve the challenges facing the medical industry as it relates to the opioid addition epidemic. Ian is dedicated to delivering innovative products that ease the burden facing medical providers and improve overall patient care.
